Antiepileptic Drugs (AEDs) Polypharmacy Could Lead to Buried Pharmacokinetic Interactions due to CYP450

Author(s): Z. Tolou-Ghamari.

Journal Name: Drug Metabolism Letters

Volume 6 , Issue 3 , 2012

Become EABM
Become Reviewer


CYP450 enzymes are basics for the metabolism of several medications such as numerous AEDs. As AEDs polypharmacy could lead to hidden pharmacokinetic interactions due to CYP450, therefore, the aim of this study was to determine a proper guideline for AEDs prescription in Iranian epileptic population. A cross-sectional study of fifty-four patients’ (n=23 females; n= 31 males with a mean age of 27 years) located in the Epilepsy Ward of Kashani Hospital of Isfahan University of Medical Sciences was carried out during the year 2011. Variables including sex, age, age of seizure onset, type and number of AEDs were recorded in d-Base. Results showed that the number of prescriptions based on AEDs polypharmacy was 77.8%. The most important drugs in prescriptions were carbamazepine (n=41) that is a potent inducer of CYP450 and valproic acid (n=31) that is a potent inhibitor of CYP450 simultaneously. Administration of AEDs was based on: three (n=17), four (n=7), five (n=4) or six (n=3) AEDs simultaneously. To avoid side effects, in prescribing AEDs that act as CYP450inhibitors or inducers concomitantly, their spectrum of interactions should be predicted.

Keywords: AEDs, polypharmacy, CYP450, inducer, inhibitor.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [207 - 212]
Pages: 6
DOI: 10.2174/1872312811206030008
Price: $58

Article Metrics

PDF: 8